Latest .bd Stories

FRANKLIN LAKES, N.J., Sept. 20, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor(TM) System for Rapid Detection of Flu A+B. This new product is cleared for use in clinical settings. The new BD...

FRANKLIN LAKES, N.J., Aug. 27, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies. Sirigen's polymer technology is based on Nobel Prize-winning research in conductive plastics and creates the potential for the development of novel dyes that are...

BALTIMORE, Aug. 14, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that the new BD MAX(TM) MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88). Performed on the fully-automated BD MAX(TM) System, the assay is designed to rapidly and accurately identify patients colonized with methicillin-resistant Staphylococcus aureus (MRSA). A...

FRANKLIN LAKES, N.J., July 25, 2012 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company), today announced the launch of the BD Hyflow(TM) needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems. The optimized inner diameter of the BD Hyflow needle enables injection of highly-viscous drug formulations without the use of a larger needle that could be more painful for the patient. As there are an increasing number of...

FRANKLIN LAKES, N.J., July 23, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that it has elected Rebecca W. Rimel to its Board of Directors, effective today. Ms. Rimel, 61, is President and Chief Executive Officer of The Pew Charitable Trusts, a public charity that applies a rigorous, analytical approach to improving public policy, informing the public and stimulating civic life. "It is an honor to...

BALTIMORE, July 17, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), today announced that it obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for BD BACTEC(TM) Plus Aerobic/F blood culture bottles in plastic, previously only available in glass. Obtaining 510(k) clearance allows for increased convenience for customers without compromising the performance and quality of the system. "BD is pleased to offer our customers...

FRANKLIN LAKES, N.J., July 11, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has entered into a definitive agreement to acquire Safety Syringes, Inc., a privately held California-based company that specializes in the development of anti-needlestick devices for prefilled syringes. The acquisition, which is subject to the satisfaction of customary closing conditions, including regulatory...

FRANKLIN LAKES, N.J., June 28, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2012 earnings conference call on Thursday, August 2, 2012, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be...

FRANKLIN LAKES, N.J., May 30, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Goldman Sachs 33rd Annual Global Healthcare Conference on Wednesday, June 6, 2012, at 1:00 pm (ET). A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Wednesday, June 13, 2012. About BDBD is a...

FRANKLIN LAKES, N.J., May 22, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Chief Executive Officer and President Vincent A. Forlenza will assume additional responsibility as Chairman of the Board, effective July 1, 2012, following his appointment by the Board of Directors. Mr. Forlenza will succeed Edward J. Ludwig, who is retiring from BD. "Vince has demonstrated strong leadership and...